Doing a little market research today…Mercury’s mobile is really slick for HL integrations https://t.co/IddNje2Lyv ...

[تصفيق] ام في مقوله شهيره لتوني روبنز بيحكي فيها انه النجاح بيجي من القرارات الصحيحه والقرارات الصحيحه بتيجي من الخبره والخبره بتيجي من التجارب الفاشله وانا سيد التجارب الفاشله ايه رح احكي لكم عن تجربتي خلال 11 سنه الماضيه تخرجت في السبعه 97 مهندس كنت فخور اني مهندس سعيد بحرف الميم قبل اسمي تخرجت وبدات اشتغل في عدد من الشركات ال الاردنيه والاقليميه شركات كبيره بلشت اكبر فيها وكل ما كنت اكبر فيها كل ما كنت اشوف الموضوع بشكل مختلف الهندسه مش فقط هندسه الهندسه في كان في داخلي اه رائد اعمال صغير كان كل فتره يدع ...

Core Insights - Unilever ranks sixth in global snacks sales and is the leader in the ice cream category, holding 20% of retail value sales worldwide [2] - A demerger of Unilever's ice cream business is planned by the end of the 2025 financial year, which will impact the group's overall earnings figures starting in 2024 [2] Company Profile Overview - The "Unilever Group in Snacks" company profile provides a strategic analysis of the company's performance in the snacks industry, including regional and category shares, brand portfolio, new product developments, market strategies, competitive challenges, and future prospects [3] - The report covers various product categories including Confectionery, Ice Cream, Savoury Snacks, Sweet Biscuits, Snack Bars, and Fruit Snacks, along with market sizes, company shares, brand shares, and distribution data [4] Market Insights - The report aims to provide a detailed understanding of the snacks market, identify growth sectors, and analyze factors driving change [7] - It includes five-year forecasts to assess the predicted development of the market, focusing on competitive positioning and exposure to future growth [7]

Summary of Conference Call Records Industry Overview - The conference call discusses the performance of various food and beverage brands within the membership store channel, particularly focusing on snacks, dairy products, and health supplements [1][2][3]. Key Points and Arguments Sales Performance - **Youyou Duck Feet**: Sales increased from 27 million yuan in March to 28 million yuan in May, indicating strong market demand and growth potential [1][4]. - **Qing Tian Shi**: Initial sales of 2.2 million yuan in April rose to 6.95 million yuan in May due to improved raw material supply, highlighting market potential but also emphasizing supply chain stability as a risk factor [1][2][4]. - **Egg Yolk Quail Eggs**: Sales dropped to 15 million yuan in May from 17 million yuan in March and April, affected by seasonal fluctuations and negative news, indicating market volatility risks [1][4]. - **Zhou Hei Ya Classic Dipping Sauce**: Sales grew from 1.85 million yuan in April to over 3.4 million yuan in May, suggesting high acceptance of new products but potential cannibalization of existing products [1][6]. - **Tiramisu**: Sales remained stable between 9.5 million to 10 million yuan, but short shelf life and complex supply chain management pose risks [1][7]. Market Trends - The health supplement sector is experiencing a slowdown, with expected growth rates of 5%-8% for 2024-2025, lower than other categories like beverages and electronics, necessitating a reassessment of market strategies [3][9]. - The overall food category in membership stores includes approximately 1,200 SKUs, with a significant focus on rice, oil, nuts, and frozen foods [3][10]. Product Innovation and Development - Many small food and dairy companies are leveraging brand and product innovation to drive performance, as seen with Youyou Duck Feet and Qing Tian Shi [2]. - New product launches, such as the Frankie TT Cotto beef jerky and probiotics electrolyte powder, are currently in single-channel sales stages, with data expected by the end of July [5]. SKU Management and Consumer Feedback - The membership store collects around 20,000 member feedback entries daily to inform new product development and SKU optimization, ensuring alignment with market demand [3][14][15]. - New products undergo a protection period of three to six months, during which performance is evaluated before broader distribution [16]. Localization Strategy - The membership store has successfully implemented a localization strategy, enhancing its ability to discover and cater to local tastes, which has led to significant revenue growth [21][22]. Additional Important Insights - The sales data for various products indicate a trend of fluctuating performance, emphasizing the need for effective crisis management and quality control [1][4]. - The competitive landscape shows that the membership store's localized approach has outperformed competitors like Costco, which lacks a similar strategy [21][22].

Group 1 - The focus is on fundamental analysis and disciplined market research to identify investment opportunities [1] - Emphasis on small cap companies with strong fundamentals and growth potential, large cap companies facing temporary setbacks, and stable companies with solid dividend yields [1] Group 2 - No stock or derivative positions in mentioned companies, indicating an unbiased perspective [2] - The article expresses personal opinions and is not influenced by compensation from companies mentioned [2]

How QY Research Conducts Market Research and Interviews: A Behind-the-Scenes Look In today's fast-paced business world, accurate and actionable insights are crucial for staying ahead. At QY Research, we understand that exceptional market research doesn't happen by chance—it's the result of a systematic, meticulous process. Here's an inside look at how QY Research conducts market research and interviews to deliver trusted, high-quality intelligence to our clients. 1 Clarifying Research Goals and Client Needs ...

Core Insights - The focus is on fundamental analysis and disciplined market research to identify investment opportunities in small cap companies with strong fundamentals, large cap companies facing temporary setbacks, and stable companies with solid dividend yields and growth potential [1]. Group 1 - The analyst has a strong quantitative background with a Ph.D. in Chemical Engineering and an MBA, indicating a robust analytical capability [1]. - The investment strategy emphasizes identifying small cap companies with growth potential, which may present unique opportunities for investors [1]. - Large cap companies undergoing temporary setbacks are also a focus, suggesting a strategy to capitalize on recovery potential [1]. Group 2 - The emphasis on stable companies with solid dividend yields indicates a preference for income-generating investments alongside growth [1].

Financial Data and Key Metrics Changes - In Q4 2024, YUPELRI net sales increased by 10% year-over-year, reaching $66.7 million, marking an all-time high [4] - Full year YUPELRI sales totaled $239 million, with an 8% increase in net sales for 2024 and an 11% growth in demand [11][14] - Collaboration revenue grew by 8% to approximately $19 million in Q4 [32] - Operating expenses, excluding share-based compensation, increased to $22 million due to higher commercial and medical affairs spending [32] Business Line Data and Key Metrics Changes - YUPELRI's hospital performance saw doses increase by 49% year-over-year, with 285,000 redoses pulled through to hospital customers [4][13] - The hospital business accounts for roughly 10% of total YUPELRI volume, with 90% coming from community settings [77] - Ample enrollment in the CYPRESS study for ampreloxetine is on track, with expectations for expedited NDA filing [5][20] Market Data and Key Metrics Changes - TRELEGY reported full year sales of $3.5 billion, up 26% year-over-year, triggering a $50 million milestone payment [15] - The company anticipates achieving an additional $150 million in milestones from TRELEGY in 2025 and 2026 [16] Company Strategy and Development Direction - The company aims to grow YUPELRI revenue while increasing brand profitability, with potential near-term sales milestones in the U.S. and royalties from China [7] - For ampreloxetine, the focus is on completing enrollment in the CYPRESS study and preparing for an expedited NDA filing [8] - The company is committed to maximizing the value of TRELEGY and returning excess capital to shareholders [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the financial position entering 2025, with $88 million in cash and no debt [39] - The company is focused on driving YUPELRI growth through strong demand generation and a patient-centered strategy [40] - Management highlighted the potential impact of ampreloxetine on patients with MSA suffering from nOH symptoms [41] Other Important Information - The company completed market research indicating a significant unmet need for better nOH therapies, with over 70% of surveyed neurologists agreeing [25] - The target product profile for ampreloxetine aligns with physician preferences, suggesting a favorable outlook if approved [28] Q&A Session Summary Question: What drove the success in the hospital channel this quarter? - The success was attributed to effective execution of strategy and wins in larger systems, with therapeutic interchange contributing to increased volume [45][46] Question: What is the trend for the hospital performance into 2025? - Q1 is typically softer, but there is a demonstrated need for YUPELRI, which may provide a tailwind [60] Question: What are the next steps for YUPELRI in China? - The company is waiting for regulatory feedback from Viatris, with a typical two-year window expected from submission to approval [62] Question: What was the nature of the recent FDA feedback on ampreloxetine? - The feedback was from a Type C meeting to clarify filing content and ensure alignment on key requirements for full approval [67] Question: What percentage of YUPELRI sales are non-hospital sales? - The hospital business accounts for roughly 10% of total YUPELRI volume, with the community setting making up the majority [77] Question: What is the bar for success for the CYPRESS readout? - A one-point change in the OHSA composite score is considered clinically meaningful for success [88]